Physician profile
Heather Doty
NPI 1427038348
$527.50
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.33 · 2020: $106 · 2021: $321 · 2022: $16.57.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $192.21 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.11 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $58.94 | 2021 | |
| Abbott Laboratories | $39.06 | 2021 | |
| Dexcom, INC. | $29.66 | 2021 | |
| Hologic Sales and Service, LLC | $21.45 | 2019 | |
| Lilly USA, LLC | $16.82 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.41 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.44 | 2021 | |
| Janssen Scientific Affairs, LLC | $15.35 | 2020 | |
| Ibsa Pharma INC. | $14.52 | 2020 | |
| Coopersurgical, INC. | $13.55 | 2020 | |
| Amgen INC. | $13.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Doty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.